Alimera Sciences, Inc. Sustainability Profile
Alimera Sciences, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States and focuses on innovative therapies for retinal diseases. Founded in 2003, the company has made significant strides in developing and commercialising treatments that address unmet medical needs in ophthalmology. Alimera's flagship product, ILUVIEN®, is a sustained-release implant designed for the treatment of diabetic macular oedema, setting it apart with its unique delivery system that provides long-term efficacy. With a strong market presence, particularly in North America and Europe, Alimera Sciences has established itself as a leader in the field, committed to improving patient outcomes through cutting-edge research and development.
DitchCarbon Score
How does Alimera Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alimera Sciences, Inc.'s score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alimera Sciences, Inc.'s reported carbon emissions
Alimera Sciences, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. It is important to note that Alimera Sciences, Inc. is a current subsidiary and may inherit emissions data from its parent organisation. However, no specific emissions data or reduction initiatives have been cascaded from the parent company. In the context of the industry, many companies are increasingly committing to science-based targets and sustainability initiatives. Alimera Sciences, Inc. has yet to establish or disclose any such commitments, which may be a consideration for stakeholders interested in the company's environmental impact and climate strategy.
How Carbon Intensive is Alimera Sciences, Inc.'s Industry?
How Carbon Intensive is Alimera Sciences, Inc.'s Location?
Alimera Sciences, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alimera Sciences, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.